We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

In the last reported quarter, the company’s earnings per share (EPS) of $3.50 surpassed the Zacks Consensus Estimate by 5.7%.

With a market cap of $68.8 billion, Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a leading global ...

2024--(BUSINESS WIRE)--Babson Diagnostics, a science-first healthcare technology company, today announced that BD (Becton, Dickinson and Company), a leading global medical technology company ...

CX Institutional grew its stake in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 128.6% during the third quarter, ...

The firm said that the updated approval will improve access to HPV testing by providing a less invasive and less expensive alternative to Pap tests.

CENTRAL TRUST Co lowered its holdings in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 43.4% during the 3rd ...

DUBLIN--(BUSINESS WIRE)--The "Uterine Cancer Therapeutics and Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...

Becton, Dickinson and Company announced a strategic collaboration with Ypsomed, a developer of injection systems, to advance self-injection ...

New Jersey-based Becton, Dickinson and Company (BDX) is a leading global medical technology firm. It develops and supplies medical devices, diagnostic products, and lab equipment globally ...